Pittenger & Anderson Inc. Sells 153 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pittenger & Anderson Inc. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the fourth quarter, Holdings Channel reports. The fund owned 59,491 shares of the medical equipment provider’s stock after selling 153 shares during the period. Intuitive Surgical makes up about 1.1% of Pittenger & Anderson Inc.’s portfolio, making the stock its 18th biggest position. Pittenger & Anderson Inc.’s holdings in Intuitive Surgical were worth $31,052,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ISRG. Catalyst Capital Advisors LLC boosted its position in Intuitive Surgical by 132.5% in the 4th quarter. Catalyst Capital Advisors LLC now owns 637 shares of the medical equipment provider’s stock valued at $332,000 after buying an additional 363 shares during the last quarter. AlphaCentric Advisors LLC boosted its position in Intuitive Surgical by 196.5% in the 4th quarter. AlphaCentric Advisors LLC now owns 3,706 shares of the medical equipment provider’s stock valued at $1,934,000 after buying an additional 2,456 shares during the last quarter. Nicholas Hoffman & Company LLC. bought a new position in Intuitive Surgical in the 4th quarter valued at $241,000. Americana Partners LLC boosted its position in Intuitive Surgical by 6.5% in the 4th quarter. Americana Partners LLC now owns 3,667 shares of the medical equipment provider’s stock valued at $1,914,000 after buying an additional 223 shares during the last quarter. Finally, Sierra Ocean LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $40,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $595.55 on Monday. The stock has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. The business has a 50-day moving average of $559.48 and a 200-day moving average of $520.19. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ISRG shares. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Truist Financial increased their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group raised their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.